Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Accepted on 17 Sep 2025

Comparison between primary and secondary central nervous system vasculitis in terms of clinical, biochemical, radiological, histopathological features, and outcomes: a single-center retrospective cohort studyPrimary central nervous system vasculitis: a single-center retrospective cohort

in Multiple Sclerosis and Neuroimmunology

Pasquale Scoppettuolo
Lucie Pothen
Aline Van Maanen
Valeria Onofrij
Selda Aydin
Olivier Gheysens
Renaud Lhommel
André Peeters
Vincent Van Pesch
Halil Yildiz

Frontiers in Neurology

doi 10.3389/fneur.2025.1602427

1,131 views

Original Research

Accepted on 17 Sep 2025

Factors influencing health behavior changes in people with early multiple sclerosis: process evaluation of the multicenter randomized controlled POWER@MS1 trial

in Multiple Sclerosis and Neuroimmunology

Barbara von Glasenapp
Nicole Krause
Carlotta Derad
Karin Riemann-Lorenz
Björn Meyer
Markus van de Loo
Herbert Temmes
Stefan Gold
Christoph Heesen
POWER@MS1 study group

Frontiers in Neurology

doi 10.3389/fneur.2025.1635872

337 views

Original Research

Published on 17 Sep 2025

Serum interleukin-40 increases in anti-AchR antibody-positive myasthenia gravis and correlates with disease activity

in Multiple Sclerosis and Neuroimmunology

Kun Jia
Yingzhe Shao
Taofeng Tan
Xuan Liu
Qiuxia Zhang
Ning Zhao
Li Yang

Frontiers in Neurology

doi 10.3389/fneur.2025.1680530

667 views

Original Research

Published on 15 Sep 2025

Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses

in Multiple Sclerosis and Neuroimmunology

Margherita Bellucci
Giovanna Capodivento
Federico Massa
Federica Bozzano
Giacomo Bavestrello
Elena Baroncelli
Corrado Cabona
Antonia Cagnetta
Angelo Schenone
Lucilla Nobbio

Frontiers in Neurology

doi 10.3389/fneur.2025.1659670

711 views

Brief Research Report

Published on 15 Sep 2025

Major depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics

in Multiple Sclerosis and Neuroimmunology

Nathanael J. Lee
Gavin Hui
C. William Pike
Kristin Galetta
Lucas B. Kipp
Jeffrey Dunn
Scheherazade Le
S. Sai Folmsbee

Frontiers in Neurology

doi 10.3389/fneur.2025.1663778

1,242 views

Original Research

Accepted on 11 Sep 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

in Multiple Sclerosis and Neuroimmunology

Gytis Makarevičius
Rasa Kizlaitienė
Gintaras Kaubrys
Nataša Giedraitienė

Frontiers in Neurology

doi 10.3389/fneur.2025.1635618

649 views

Original Research

Accepted on 10 Sep 2025

From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of Visual Evoked Potential P100-N145 amplitudes: a missing piece of the puzzle?

in Multiple Sclerosis and Neuroimmunology

Nurhan Kaya Tutar
Nilufer Kale

Frontiers in Neurology

doi 10.3389/fneur.2025.1649998

538 views

Policy and Practice Reviews

Accepted on 08 Sep 2025

Glial Fibrillary Acidic Protein Autoimmunity in Reversible Splenial Lesion Syndrome: Diagnostic and Therapeutic Implications

in Multiple Sclerosis and Neuroimmunology

Lingling Lin
Xiang Li
Chao Quan
Jingzi Zhangbao
Hongmei Tan
Yi Wang
Siyuan Xu
Zhihao Dai

Frontiers in Neurology

doi 10.3389/fneur.2025.1650256

611 views

Hypothesis and Theory

Accepted on 08 Sep 2025

System-Level Hypothesis of Dopamine Imbalance in Early Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Daniele Caligiore
Aurelia Schirripa
Monica Biggio

Frontiers in Neurology

doi 10.3389/fneur.2025.1653134

618 views

Original Research

Accepted on 04 Sep 2025

The Frequency of Psoriasis in Australian Multiple Sclerosis Patients

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes Villalba
Turlough Montague
Olivia Charlton
Chun-Ting Justin Kwong
Helen Marie McGuire
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith
John Parratt

Frontiers in Neurology

doi 10.3389/fneur.2025.1663015

703 views

Editorial

Accepted on 04 Sep 2025

Women in Multiple Sclerosis and Neuroimmunology: From Bench to Bedside

in Multiple Sclerosis and Neuroimmunology

Jessy J Alexander
Krista DiSano
Liliana Patrucco
Mireya Fernandez-Fournier

Frontiers in Neurology

doi 10.3389/fneur.2025.1677618

548 views

Original Research

Published on 02 Sep 2025

Autoimmune encephalitis in Latin America. Clinical features and outcomes in pediatric and adult populations: retrospective cohort of The REAL LABIC Project

in Multiple Sclerosis and Neuroimmunology

Miguel A. Vences
Christoper A. Alarcon Ruiz
Mary Marcela Araujo Chumacero
Diego Canales-Pichen
Victor Saquisela
Jesús Domínguez-Rojas
Donoband Melgarejo
Saúl Reyes-Niño
Cintia Johnston
Maricela García-Arellano

Frontiers in Neurology

doi 10.3389/fneur.2025.1647087

1,414 views

Original Research

Accepted on 31 Aug 2025

Evaluating the Impact of Task-Sequencing on Cognitive and Motor Performance in MS: PASAT and 3-Minute Walk Test Order Effects

in Multiple Sclerosis and Neuroimmunology

Valentin Siegert
Laura Jane Köhler
Lucas Schreff
Daniel Hamacher
Patrick Oschmann
Veit Rothhammer
Philipp Moritz Keune
Roy Müller

Frontiers in Neurology

doi 10.3389/fneur.2025.1654656

277 views

Original Research

Published on 28 Aug 2025

Aberrant lncRNA and mRNA expression in patients with anti-N-methyl-d-aspartate receptor encephalitis

in Multiple Sclerosis and Neuroimmunology

Xiaoyu Ma
Wenbo Guo
Zixuan Teng
Qingqing Yin
Chunjuan Wang
Pin Wang
Shougang Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1605982

824 views

Brief Research Report

Accepted on 27 Aug 2025

Peripheral Neuromodulation in Spasticity-Plus Syndrome: Effects of Pulsed Radiofrequency on Tonic-Painful Disorders in Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Luigi Di Lorenzo
Carmine D'Avanzo

Frontiers in Neurology

doi 10.3389/fneur.2025.1634960

367 views

Original Research

Published on 26 Aug 2025

Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies

in Multiple Sclerosis and Neuroimmunology

Yutao Liu
Yang Liu
Han Yuan
Limei Wang

Frontiers in Neurology

doi 10.3389/fneur.2025.1634127

1,170 views